Yang C, Yu Y, Peng Q, Song J, Sun B, Shi Y
Biosaf Health. 2025; 6(5):270-278.
PMID: 40078736
PMC: 11895013.
DOI: 10.1016/j.bsheal.2024.09.001.
Grelewska-Nowotko K, Elhag A, Turowski T
Wiley Interdiscip Rev RNA. 2025; 16(1):e70000.
PMID: 39757745
PMC: 11701415.
DOI: 10.1002/wrna.70000.
Lazou M, Bekar-Cesaretli A, Vajda S, Joseph-McCarthy D
Viruses. 2024; 16(11).
PMID: 39599762
PMC: 11599001.
DOI: 10.3390/v16111647.
Baker D, Wang B, Wilkinson-White L, El-Kamand S, Allport T, Ataide S
Proteins. 2024; 92(11):1308-1317.
PMID: 38958516
PMC: 11471385.
DOI: 10.1002/prot.26725.
Carvajal J, Garcia-Castillo V, Cuellar S, Campillay-Veliz C, Salazar-Ardiles C, Avellaneda A
Front Immunol. 2024; 15:1363572.
PMID: 38911850
PMC: 11190347.
DOI: 10.3389/fimmu.2024.1363572.
Inhibition of SARS-CoV-2 Nsp9 ssDNA-Binding Activity and Cytotoxic Effects on H838, H1975, and A549 Human Non-Small Cell Lung Cancer Cells: Exploring the Potential of Leaf Extract for Pulmonary Disease Treatment.
Su H, Lin E, Huang Y, Lien Y, Huang C
Int J Mol Sci. 2024; 25(11).
PMID: 38892307
PMC: 11173125.
DOI: 10.3390/ijms25116120.
Mutations in nonstructural proteins essential for pathogenicity in SARS-CoV-2-infected mice.
Pan R, Li P, Meyerholz D, Perlman S
J Virol. 2024; 98(7):e0058424.
PMID: 38888344
PMC: 11265370.
DOI: 10.1128/jvi.00584-24.
Characteristics of SARS-CoV-2 Omicron BA.5 variants in Shanghai after ending the zero-COVID policy in December 2022: a clinical and genomic analysis.
Liu P, Cai J, Tian H, Li J, Lu L, Xu M
Front Microbiol. 2024; 15:1372078.
PMID: 38605705
PMC: 11007228.
DOI: 10.3389/fmicb.2024.1372078.
Bio-Chemoinformatics-Driven Analysis of nsp7 and nsp8 Mutations and Their Effects on Viral Replication Protein Complex Stability.
Subong B, Ozawa T
Curr Issues Mol Biol. 2024; 46(3):2598-2619.
PMID: 38534781
PMC: 10968879.
DOI: 10.3390/cimb46030165.
SHIFTR enables the unbiased identification of proteins bound to specific RNA regions in live cells.
Aydin J, Gabel A, Zielinski S, Ganskih S, Schmidt N, Hartigan C
Nucleic Acids Res. 2024; 52(5):e26.
PMID: 38281241
PMC: 10954451.
DOI: 10.1093/nar/gkae038.
SARS-CoV-2 biology and host interactions.
Steiner S, Kratzel A, Barut G, Lang R, Aguiar Moreira E, Thomann L
Nat Rev Microbiol. 2024; 22(4):206-225.
PMID: 38225365
DOI: 10.1038/s41579-023-01003-z.
Structural basis for polyuridine tract recognition by SARS-CoV-2 Nsp15.
Ito F, Yang H, Zhou Z, Chen X
bioRxiv. 2023; .
PMID: 38045375
PMC: 10690159.
DOI: 10.1101/2023.11.17.567629.
A structural analysis of the nsp9 protein from the coronavirus MERS CoV reveals a conserved RNA binding interface.
Mani G, El-Kamand S, Wang B, Baker D, Ataide S, Artsimovitch I
Proteins. 2023; 92(3):418-426.
PMID: 37929701
PMC: 10872591.
DOI: 10.1002/prot.26630.
Structural and functional insights into the enzymatic plasticity of the SARS-CoV-2 NiRAN domain.
Small G, Fedorova O, Olinares P, Chandanani J, Banerjee A, Choi Y
Mol Cell. 2023; 83(21):3921-3930.e7.
PMID: 37890482
PMC: 10843261.
DOI: 10.1016/j.molcel.2023.10.001.
SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.
Schmidt N, Ganskih S, Wei Y, Gabel A, Zielinski S, Keshishian H
Cell. 2023; 186(22):4834-4850.e23.
PMID: 37794589
PMC: 10617981.
DOI: 10.1016/j.cell.2023.09.002.
Identification of TMEM53 as a novel SADS-CoV restriction factor that targets viral RNA-dependent RNA polymerase.
Yao Y, Luo Y, Wang Q, Geng R, Chen Y, Liu M
Emerg Microbes Infect. 2023; 12(2):2249120.
PMID: 37584551
PMC: 10467534.
DOI: 10.1080/22221751.2023.2249120.
Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China.
Yang L, Wang Z
Eur J Med Chem. 2023; 257:115503.
PMID: 37229831
PMC: 10193775.
DOI: 10.1016/j.ejmech.2023.115503.
Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus NiRAN Domains.
Slanina H, Madhugiri R, Wenk K, Reinke T, Schultheiss K, Schultheis J
J Virol. 2023; 97(6):e0046523.
PMID: 37199624
PMC: 10308930.
DOI: 10.1128/jvi.00465-23.
Contribution to pathogenesis of accessory proteins of deadly human coronaviruses.
Hurtado-Tamayo J, Requena-Platek R, Enjuanes L, Bello-Perez M, Sola I
Front Cell Infect Microbiol. 2023; 13:1166839.
PMID: 37197199
PMC: 10183600.
DOI: 10.3389/fcimb.2023.1166839.
Therapeutic strategies for COVID-19: progress and lessons learned.
Li G, Hilgenfeld R, Whitley R, De Clercq E
Nat Rev Drug Discov. 2023; 22(6):449-475.
PMID: 37076602
PMC: 10113999.
DOI: 10.1038/s41573-023-00672-y.